BSX

Boston Scientific
D

BSX

Arincen84/100B

Boston Scientific net income 1991–2026

Boston Scientific earned 578.00M USD in Q3 FY2026, the three months to 30 September 2026, down 23.4% on the same quarter a year before. Boston Scientific's net income over the last twelve months was 3.49B USD, up 25.2% on the twelve months before. In fiscal year 2025 it earned 2.89B USD, up 55.7% on the year before.

Last updated 7 Nov 2026 · Next report 3 Feb 2027

Net income

Net income Net margin

Growth

Fiscal yearPeriod endingNet incomeGrowthNet marginRevenue
TTM30 Sept 20263.49B+25.18%16.56%21.07B
FY202531 Dec 20252.89B+55.66%14.38%20.07B
FY202431 Dec 20241.85B+16.38%11.07%16.75B
FY202331 Dec 20231.59B+128.22%11.19%14.24B
FY202231 Dec 2022698.00M-32.88%5.50%12.68B
FY202131 Dec 20211.04B—8.75%11.89B
FY202031 Dec 2020-82.00M-101.74%-0.83%9.91B
FY201931 Dec 20194.70B+181.27%43.78%10.74B
FY201831 Dec 20181.67B+1,506.73%17.01%9.82B
FY201731 Dec 2017104.00M-70.03%1.15%9.05B
FY201631 Dec 2016347.00M—4.14%8.39B
FY201531 Dec 2015-239.00M—-3.20%7.48B
FY201431 Dec 2014-119.00M—-1.61%7.38B
FY201331 Dec 2013-121.00M—-1.69%7.14B
FY201231 Dec 2012-4.07B-1,022.45%-56.12%7.25B
FY201131 Dec 2011441.00M—5.79%7.62B
FY201031 Dec 2010-1.07B—-13.64%7.81B
FY200931 Dec 2009-1.03B—-12.52%8.19B
FY200831 Dec 2008-2.04B—-25.29%8.05B
FY200731 Dec 2007-495.00M—-5.92%8.36B
FY200631 Dec 2006-3.58B-669.59%-45.74%7.82B
FY200531 Dec 2005628.00M-40.87%10.00%6.28B
FY200431 Dec 20041.06B+125.00%18.88%5.62B
FY200331 Dec 2003472.00M+26.54%13.58%3.48B
FY200231 Dec 2002373.00M—12.78%2.92B
FY200131 Dec 2001-54.00M-114.48%-2.02%2.67B
FY200031 Dec 2000373.00M+0.54%14.00%2.66B
FY199931 Dec 1999371.00M—13.05%2.84B
FY199831 Dec 1998-264.40M-289.81%-11.84%2.23B
FY199731 Dec 1997139.30M-16.64%7.44%1.87B
FY199631 Dec 1996167.10M+1,988.75%11.43%1.46B
FY199531 Dec 19958.00M-89.96%0.72%1.11B
FY199431 Dec 199479.70M+14.35%17.75%448.90M
FY199331 Dec 199369.70M+23.14%18.34%380.10M
FY199231 Dec 199256.60M+35.41%17.96%315.20M
FY199131 Dec 199141.80M—18.17%230.00M

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about Boston Scientific's profit

Source: Financial Modeling Prep